Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Remsima 100 mg powder for concentrate for solution for infusion

Active Ingredient:
infliximab
Company:  
Celltrion Healthcare UK Limited See contact details
About Medicine
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine.
{info_black}
Last updated on emc: 21 Mar 2024
Celltrion Healthcare UK Limited
Company image
Address
Celltrion Healthcare UK Limited, The Switch, 1-7 The Grove, Slough, Berkshire, SL1 1QP
Telephone
01753 983 500
Medical Information Direct Line
01753 983 500
Medical Information e-mail
[email protected]
Customer Care direct line
01753 983 500
Adverse event reporting email
[email protected]